Gastroparesis can be caused by several conditions, including: Diabetes (most common traditional cause) High blood sugar can damage nerves involved in stomach motility
Teriparatide has a known safety profile from clinical use but carries a boxed warning regarding osteosarcoma risk observed in rats
However, even slight variations, such as alterations in the dimensions of lipoprotein particles and an elevation in LDL II and IV subtypes, could potentially contribute to an increased susceptibility to macrovascular disease in people [107]
1 In 2024, draft guidance recommended use of Mounjaro for obesity in primary care settings at a lower threshold of body mass index (BMI), with no restriction on treatment duration
Ryu S, Chang Y, Kim YS, et al